Evidence map›Paper›PMID 35847034›Full record

ReviewFrontiers in pharmacology2022

The

Hui Zhao, Ya-Long Feng, Ming Wang, Jing-Jing Wang, Tian Liu, Jun Yu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
23.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Advancing the Potential ofPlants (Basel, Switzerland) · 2026
    Article
  8. Effects of Solid-State Fermentation byFoods (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Role of oxeiptosis in disease mechanisms and therapeutic opportunities.Apoptosis : an international journal on programmed cell death · 2025
    Review
  17. Article
  18. Exploring the Toxicity and Therapeutic Potential ofInternational journal of molecular sciences · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hui ZhaoClinical Experimental Center, Xi'an International Medical Center Hospital, Xi'an, China.
Ya-Long FengSchool of Chemistry and Chemical Engineering, Xianyang Normal University, Xianyang, China.
Ming WangCollege of Food Science and Engineering, Northwest University, Xi'an, China.
Jing-Jing WangBiomedicine Key Laboratory of Shaanxi Province, College of Life Science, Northwest University, Xi'an, China.
Tian LiuClinical Experimental Center, Xi'an International Medical Center Hospital, Xi'an, China.
Jun YuClinical Experimental Center, Xi'an International Medical Center Hospital, Xi'an, China.
Northwest University · CNXianyang Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angelica dahuricaanti-inflammationanti-tumorcoumarinsimperatorinreview

Identifiers

PMID35847034
PMCPMC9283917
OpenAlexW4283749678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.